News from SDCC

​Researchers at Steno Diabetes Center have developed a new tool that can help physicians predict the risk of cardiovascular disease in people with type 1 diabetes. The goal is to prevent fatal cardiovascular events.

​Research from Steno Diabetes Center provides new knowledge about the biology of non-alcoholic fatty liver disease (NAFLD) that may explain how people with NAFLD develop type 2 diabetes.

​The metabolomics research group at Steno Diabetes Center is part of a new pan-European partnership to improve the understanding and prevention of type 1 diabetes.

​In the future Steno Diabetes Center and the University of Copenhagen will have an even closer collaboration to improve the lives of people with diabetes. Steno hosted a joint seminar to mark the collaboration.

​The PULSE project developed in collaboration with Steno Diabetes Center has been nominated as promising practice example by EU for its ability to build a strong link between society and research.

​The research Consortium GALAXY which involves among others Steno Diabetes Center and University of Southern Denmark has just received 6.3 million € from the European Union’s Horizon 2020 research and innovation programme to combat cirrhosis of the liver, which has a lower survival rate than several types of cancer.

​Professor at Steno Diabetes Center, Peter Rossing, receives the Lassen award for his research within diabetes complications.

​New research from Steno Diabetes Center shows that persons who are diagnosed with diabetes have a lower income compared to people without diabetes five years after their diagnosis.

​Steno Diabetes Center is partner in Cities Changing Diabetes, a global programme to fight the growth of diabetes in major cities.

​Senior researcher at Steno Diabetes Center Kristine Færch receives the ”Young Investigator Award” from the Danish Diabetes Academy for her work on type 2 diabetes subtypes.